MORGANN DELOACH: Open Payments
NPI 1841949724 · BUFORD, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$636 in 18 payments from 11 companies in 2025. Trend: 2023 $760 · 2024 $150 · 2025 $636
Food & beverage: $636
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $142 |
| Astellas Pharma US Inc | 1 | $129 |
| Gilead Sciences, Inc. | 1 | $122 |
| AstraZeneca Pharmaceuticals LP | 3 | $96 |
| ABBVIE INC. | 2 | $30 |
| Lilly USA, LLC | 1 | $27 |
| SANOFI PASTEUR INC. | 1 | $20 |
| PFIZER INC. | 1 | $20 |
| Merck Sharp & Dohme LLC | 1 | $19 |
| Exact Sciences Corporation | 1 | $17 |
Products named: Veozah, Descovy, Ozempic, BREZTRI, VRAYLAR, MOUNJARO, AIRSUPRA, FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE.
Industry payments across GA — which companies pay providers there.
